AgTech Navigator News

  • Agrii’s UK farm trials show that using digital tools to guide fungicide timing, rather than simply reducing inputs, can improve wheat yield and crop health. By combining disease modelling, spore detection, and on-farm observation, the trials allowed for reduced early fungicide use when risk was low, shifting resources to targeted interventions as disease pressure increased. The overall fungicide spend was similar to standard practice, but yields increased by 0.8 t/ha due to better crop health and responsive management. The results highlight that technology enhances agronomy by enabling more flexible and informed decisions, not by replacing expert judgment or radically cutting inputs.
  • Brazilian farmers’ heavy use of WhatsApp is laying the ground work for an AI agricultural revolution
  • Tunisian scientists have fully sequenced the genomes of two heritage durum wheat varieties, Mahmoudi and Chili, both renowned for their resilience to drought, heat, and disease. By making these genome assemblies publicly available, the researchers aim to help breeders worldwide develop more climate-resilient wheat at a time of increasing environmental challenges. Mahmoudi and Chili, deeply rooted in Tunisia’s agricultural history, offer genetic traits largely lost in modern wheat, such as high protein content and strong disease resistance. The project was led by the University of Sfax and the National Gene Bank of Tunisia, with international collaboration and support.
  • At Bayer’s 2026 Annual Stockholders’ Meeting, shareholder frustration centered on the ongoing fallout from the Monsanto acquisition and US glyphosate litigation, prompting CEO Bill Anderson to emphasize operational improvements and a shift toward precision crop protection technologies. The company announced a five-year plan for its Crop Science division focused on tighter margins, portfolio rationalization, and innovation, with new products like Plenexos and PRECEON™ short corn positioned as future growth drivers. Anderson highlighted that litigation risk is constraining industry innovation and called for regulatory certainty, while shareholders approved a minimum dividend to prioritize debt reduction and self-funded R&D. Bayer is betting on a leaner, more innovative Crop Science division to restore growth once legal uncertainties subside.